Epidemiological and Demographic Study of Patients with Mucormycosis and COVID-19

Nader Saki; Alireza Rafati Navaei; Ali Delirrooyfard; Mina Jahangiri; Roomina Bagheri

추천

검색

자료유형: 학술저널

저자정보: Nader Saki (Ahvaz Jundishapur University of Medical Sciences) Alireza Rafati Navaei (Ahvaz Jundishapur University of Medical Sciences) Ali Delirrooyfard (Ahvaz Jundishapur University of Medical Sciences) Mina Jahangiri (Ahvaz Jundishapur University of Medical Sciences) Roomina Bagheri (Ahvaz Jundishapur University of Medical Sciences)

저널정보: 대한의진균학회 대한의진균학회지 대한의진균학회지 제28권 제2호

발행연도: 2023.6

수록면: 35 - 41 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Coronavirus disease 2019 (COVID-19) is associated with many bacterial and fungal diseases. Aspergillus and Candida have been reported as major pathogens resulting to comorbid infections in COVID-19 patients. Objective: Recent studies have shown a considerable burden of cases affected by mucormycosis after coronavirus disease 2019 (COVID-19) infection worldwide, and some underlying factors may contribute to this condition. Hence, this study aimed to investigate the epidemiology and demographic characteristics of mucormycosis patients after COVID-19 infection in the Ahvaz province of Iran. Methods: This descriptive-analytical epidemiological study was conducted on patients who developed mucormycosis following COVID-19 for a 6-month period in 2021. A checklist based on symptoms and possible risk factors was used to collect patient information. Results: The results showed that conjunctivitis, ophthalmalgia, facial swelling, feeling of pain or pressure in the face, and sinusitis were the most common clinical manifestations of patients with mucormycosis following COVID-19. Additionally, there was a significant association between corticosteroid and prophylactic antibiotic use, pain or pressure in the face, and ophthalmalgia with the outcome variables including alive or dead (p-values = 0.002, 0.011, 0.034, and 0.004, respectively). No statistically significant difference was found between the ages of the two groups (p-value = 0.495). Conclusion: The study findings revealed that the most common risk factors for mortality include diabetes, immune system defects, and use of prophylactic antibiotics or corticosteroids.

#COVID-19 #Epidemiology #Mucormycosis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!